IGF1 and metabolic syndrome: Our data show that higher levels of IGF-1 were predisposed to significantly greater improvements in intrahepatic lipids and in the visceral fat volume, markers which are strongly associated with metabolic syndrome, insulin resistance, and diabetes risk despite comparable weight loss.